Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd 00:00:00

Share On Facebook Share On Twitter

Sienna Cancer Diagnostics Limited (ASX:SDX) CEO, Matthew Hoskin discusses positive Johns Hopkins hTERT test results and the progress the company is making.

Recent Videos